Invention Grant
US08734383B2 Method and device for improving glycemic control based on residual insulin
有权
基于残留胰岛素改善血糖控制的方法和装置
- Patent Title: Method and device for improving glycemic control based on residual insulin
- Patent Title (中): 基于残留胰岛素改善血糖控制的方法和装置
-
Application No.: US13380287Application Date: 2010-06-23
-
Publication No.: US08734383B2Publication Date: 2014-05-27
- Inventor: Ofer Yodfat , Iddo Gescheit , Gali Shapira
- Applicant: Ofer Yodfat , Iddo Gescheit , Gali Shapira
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee: Roche Diagnostics Operations, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Roche Diagnostics Operations, Inc.
- International Application: PCT/IL2010/000501 WO 20100623
- International Announcement: WO2010/150257 WO 20101229
- Main IPC: A61M5/168
- IPC: A61M5/168 ; A61M5/172 ; A61B5/145 ; A61B5/00

Abstract:
Disclosed are systems, devices, and methods, including a system that includes a processor-based device implementing at least a residual insulin (RI) determination unit configured to determine a residual insulin in the patient's body at a particular time instance based on bolus doses previously delivered to the body of the patient, each bolus dose being associated with at least one dose value and a time representative of the time that dose value was delivered to the patient's body, and based on dose dependent RI time records that each includes at least a dose value and an associated duration value representative of dose-dependent duration of therapeutic effectiveness of the associated at least the dose value. The system also includes a pump to controllably dispense the insulin from a reservoir to the body of the patient based on the residual insulin determined by the RI determination unit.
Public/Granted literature
- US20120220939A1 METHOD AND DEVICE FOR IMPROVING GLYCEMIC CONTROL BASED ON RESIDUAL INSULIN Public/Granted day:2012-08-30
Information query
IPC分类: